We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Register to vote Register by 18 June to vote in the General Election on 4 July.
Information about COVID-19 and pregnancy from the Royal College of Obstretricians and Gynaecologists (RCOG).
Details the government's response to the IMMDS Review report. Sets out action the government will take to implement the recommendations accepted and improve patient safety.
Topical steroid products are safe and highly effective treatments for the management of a wide range of inflammatory skin diseases but have important risks, especially with prolonged use at high potency. In the coming months, as a result of regulatory...
Find out about the symptoms of COVID-19, what to do if you or your child has them and when to get medical help.
Application form to become a Maritime and Coastguard Agency (MCA) approved doctor.
General information for medical professionals about the assessing fitness to drive guide.
How to use an ethnographic study to evaluate your digital health product.
Systemic fluoroquinolones must now only be prescribed when other commonly recommended antibiotics are inappropriate. This follows a review by the MHRA which looked at the effectiveness of current measures to reduce the identified risk of disabling and potentially long-lasting or...
A patient alert card is being introduced for men taking finasteride to help raise awareness of the risk of psychiatric side effects and sexual dysfunction, including the potential for sexual dysfunction to persist after treatment has stopped. Healthcare professionals are...
We want to remind healthcare professionals that use of systemic (oral and injectable) NSAIDs such as ibuprofen, naproxen, and diclofenac is contraindicated in the last trimester of pregnancy (after 28 weeks of pregnancy).
Updates on progress to implement the 2021 government response to the Independent Medicines and Medical Devices Safety Review and improve patient safety.
Patients requiring treatment outside of hospitals will be able to choose between multiple providers across the NHS and independent sector.
This document provides information on the NHS abdominal aortic aneurysm (AAA) screening programme.
Advice and guidance on the health needs of migrant patients for healthcare practitioners.
How to use a cost benefit analysis to evaluate your digital health product.
Information on taking, submitting and processing samples which potentially contain monkeypox virus.
Guidance for industry on flexible approaches to regulation we are taking during the COVID-19 outbreak.
Safety leaflet on topical corticosteroids and withdrawal reactions to help patients and their carers to use these medicines safely.
Directory of current ICH Guidelines which have been implemented by the Medicines and Healthcare products Regulatory Agency.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab).